April 10, 2008 - SenoRx Inc. gained CE Mark approval to apply its SenoSonix with EnCor, an integration of its EnCor breast biopsy system with an Ultrasonix ultrasound imaging system; the two companies received 510(k) clearance in the U.S for the SenoSonix system in October 2007.
The vacuum-assisted EnCor breast biopsy system is integrated with an ultrasound system developed and sold by Ultrasonix Medical Corp. of Canada. The fully programmable, automated, multimodality, modular system offers both open and closed tissue collection.
Launched in November 2005, the EnCor system has marked over 500 installations in the U.S. and Canada. In Q407, EnCor was launched in Europe, while the Sonix series of Smart Ultrasound systems was launched in 2005 and has placed over 1,000 systems worldwide.
For more information: www.senorx.com, www.ultrasonix.com
April 24, 2024 
